Quantcast
Last updated on April 21, 2014 at 4:54 EDT

Latest Connective tissue disease Stories

2014-03-05 23:23:54

The Ehlers-Danlos National Foundation (EDNF) is pleased to announce that registration for the world’s largest gathering of people with Ehlers-Danlos syndrome (EDS), family caregivers, and experts, the EDNF 2014 Learning Conference, opened today. At EDNF’s conference, to be held July 10-12, 2014 in Houston, Texas at the Hilton Americas Hotel, EDS patients will connect with knowledgeable professionals in the medical community and other EDS patients. McLean, VA (PRWEB) March 05, 2014 The...

2014-01-12 23:02:50

Wintertime weather can affect more than just your mood; it can have a significant impact on your health as well – particularly if you are among the 50 million adults suffering from arthritis in the US. Dr. Jack Waxman of NCMA’s FountainGrove Rheumatology can help you understand and manage the symptoms associated with arthritis including those worsened by cold weather. Santa Rosa, CA (PRWEB) January 12, 2014 Anyone who suffers from arthritis pain can tell you that their joints do...

2013-11-04 08:27:21

ALBUQUERQUE, N.M., Nov. 4, 2013 /PRNewswire/ -- Exagen Diagnostics, Inc. and Capital Royalty Partners II, L.P. announced that they have closed a senior secured loan for up to $25 million of capital. Exagen is a patient-focused, discovery-driven, CLIA-registered, CAP-accredited laboratory with a growing menu of proprietary, internally developed tests focused on rheumatology. Exagen's lead test, SLE+, rules in-or-out Systemic Lupus Erythematosus (SLE) and provides results on 14 other...

2013-08-13 12:26:53

Annual Awards Recognize Dedication and Commitment to Rare Disease Population DANVERS, Mass., Aug. 13, 2013 /PRNewswire-USNewswire/ -- The Scleroderma Foundation named Sergio A. Jimenez, M.D., its 2013 Doctor of the Year. The award recognizes a skilled physician or researcher for his or her involvement within the Foundation, and for helping provide guidance and support to the organization's patient population. Dr. Jimenez has devoted nearly four decades to the treatment of patients with...

2013-05-14 23:27:19

EDNF to fund first ever EDNF Center for Clinical Care & Research McLean, VA (PRWEB) May 14, 2013 Coulter client, Ehlers-Danlos National Foundation (EDNF) will provide funding to support a virtual center at Greater Baltimore Medical Center (GBMC) under the direction of Clair Francomano, MD, GBMC's Director of Adult Genetics. The Center will provide comprehensive clinical care for patients, professional education for physicians and a research component. Elliot Clark, EDNF board chairman,...

2012-10-25 11:25:45

ALBUQUERQUE, N.M., Oct. 25, 2012 /PRNewswire/ -- Exagen Diagnostics, Inc., a specialty focused molecular diagnostics laboratory that discovers, develops and markets proprietary tests for rheumatologists, announced today that it has received approval to offer its patent-protected Avise SLE diagnostic, SLE-Systemic Lupus Erythematosus, in New York. This certification means that the Avise SLE brand is now available to help lupus and connective tissue disease patients nationwide. Lupus is an...

2012-02-03 19:00:38

An innovative approach to genome screening has provided clues about rare mutations that may make people susceptible to brain aneurysms, predisposing them to brain bleeds, according to preliminary late-breaking research presented at the American Stroke Association´s International Stroke Conference 2012. For the first time, scientists applied a process called whole exome sequencing to seek gene mutations in families in which multiple relatives have intracranial aneurysms, a condition in...

2011-10-10 06:51:00

EASTBOURNE, England, October 10, 2011 /PRNewswire/ -- Daval International today announced positive results from its Double-Blind Placebo-Controlled Phase II Clinical Study evaluating the safety and tolerability of AIMSPRO given as a monotherapy to patients with Late Stage Established Diffuse Cutaneous Systemic Sclerosis (diffuse scleroderma). The study evaluated the effects of 4.5mg/ml doses of AIMSPRO, administered subcutaneously, twice weekly for 26 weeks compared with...

2011-05-31 12:00:00

Going Social to Spread the Word in 2011 DANVERS, Mass., May 31, 2011 /PRNewswire-USNewswire/ -- June is Scleroderma Awareness Month, and you can become an advocate for the Scleroderma Foundation by raising awareness and teaching others about this chronic, connective tissue disease. This month, join our 23 chapters and more than 145 support groups, as we work to spread the word about this devastating disease. Teaming up with the Scleroderma Foundation in 2011 to spread awareness in the...

2009-01-30 11:46:17

Mice whose fat cells were allowed to grow larger than fat cells in normal mice developed healthy obesity, when fed a high-fat diet, U.S. researchers said. Researchers at the University of Texas Southwestern Medical Center in Dallas said the fat but healthy mice lacked a protein called collagen VI, which normally surrounds fat cells and limits how large they can grow -- like a cage around a water balloon. The mice lacking collagen VI fared much better metabolically than their counterparts...